drugset / Trial / NCT02479620

Lower-Limb Adventitial Infusion of DexaMethasone Via Bullfrog to Reduce Occurrence of Restenosis After Atherectomy (ATX)-Based Revascularization

NCT02479620 ↗

Phase 2 Unknown 120 enrolled Mercator MedSystems, Inc.
RandomizedParallel-groupSingle-blindTreatment

Summary

This is a prospective, multi-center, randomized pilot study to document the effects of adventitial delivery of dexamethasone after atherectomy-based revascularizations of lesions below the knee in symptomatic patients with critical limb ischemia (CLI).

Timeline

Start
2016-06
Primary completion
2019-11
Completion
2020-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg/ml Other

Indications